BSE Live
Dec 09, 16:01Prev. Close
1703.00
Open Price
1689.05
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 09, 15:59Prev. Close
1699.60
Open Price
1685.00
Bid Price (Qty.)
1714.40 (4)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Gland Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 1,062.66 | 1,132.54 | 1,054.58 | 1,618.55 | 1,334.81 | |
| Net CashFlow From Operating Activities | 914.73 | 996.80 | 363.97 | 790.77 | 604.93 | |
| Net Cash Used In Investing Activities | 1,704.74 | -1,756.91 | 1,208.19 | -1,002.62 | -1,524.00 | |
| Net Cash Used From Financing Activities | -433.48 | -799.42 | 14.92 | 34.90 | 1,238.46 | |
| Foreign Exchange Gains / Losses | 13.13 | 7.72 | 3.00 | 3.31 | 3.58 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 2,199.12 | -1,551.81 | 1,590.08 | -173.64 | 322.97 | |
| Cash And Cash Equivalents Begin of Year | 357.09 | 1,908.90 | 318.82 | 492.46 | 169.50 | |
| Cash And Cash Equivalents End Of Year | 2,556.21 | 357.09 | 1,908.90 | 318.82 | 492.46 |
10.11.2025
Gland Standalone September 2025 Net Sales at Rs 1,074.15 crore, up 1.05% Y-o-Y
04.11.2025
04.11.2025
Gland Consolidated September 2025 Net Sales at Rs 1,486.88 crore, up 5.76% Y-o-Y
20.09.2025
Chartist Talk: Has Nifty 50 entered the third wave of its uptrend to reclaim record highs by Diwali?
10.11.2025
Gland Standalone September 2025 Net Sales at Rs 1,074.15 crore, up 1.05% Y-o-Y
04.11.2025
Gland Consolidated September 2025 Net Sales at Rs 1,486.88 crore, up 5.76% Y-o-Y
03.11.2025
Gland Pharma net profit rises 12%YoY to Rs 183.7 crore in Q2FY26
12.08.2025
Gland Consolidated June 2025 Net Sales at Rs 1,505.62 crore, up 7.41% Y-o-Y